An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling
Abstract
The transforming growth factor β isoforms, TGF-β1, -β2, and -β3, are small secreted homodimeric signaling proteins with essential roles in regulating the adaptive immune system and maintaining the extracellular matrix. However, dysregulation of the TGF-β pathway is responsible for promoting the progression of several human diseases, including cancer and fibrosis. Despite the known importance of TGF-βs in promoting disease progression, no inhibitors have been approved for use in humans. Herein, we describe an engineered TGF-β monomer, lacking the heel helix, a structural motif essential for binding the TGF-β type I receptor (TβRI) but dispensable for binding the other receptor required for TGF-β signaling, the TGF-β type II receptor (TβRII), as an alternative therapeutic modality for blocking TGF-β signaling in humans. As shown through binding studies and crystallography, the engineered monomer retained the same overall structure of native TGF-β monomers and bound TβRII in an identical manner. Cell-based luciferase assays showed that the engineered monomer functioned as a dominant negative to inhibit TGF-β signaling with a Ki of 20–70 nM. Investigation of the mechanism showed that the high affinity of the engineered monomer for TβRII, coupled with its reduced ability to non-covalently dimerize and its inability to bind and recruit TβRI,more »
- Authors:
-
more »
- Univ. of Texas Health Science Center, San Antonio, TX (United States)
- Univ. of Pittsburgh School of Medicine, Pittsburgh, PA (United States)
- Human Health Therapeutics Portfolio, Montreal, QC (Canada)
- Publication Date:
- Research Org.:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- National Inst. of Health; Robert A. Welch Foundation; National Science Foundation (NSF); Cancer Prevention Research Inst.; American Heart Assoc.
- OSTI Identifier:
- 1355043
- Grant/Contract Number:
- GM58670; CA172886; AQ1842; P30 CA54174; GM120600; ACI-1339649; RP1450105; 15PRE25550015
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Journal of Biological Chemistry
- Additional Journal Information:
- Journal Volume: 292; Journal Issue: 17; Journal ID: ISSN 0021-9258
- Publisher:
- American Society for Biochemistry and Molecular Biology
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 60 APPLIED LIFE SCIENCES; cancer; cell signaling; fibrosis; inhibitor; protein engineering; transforming growth factor beta (TGF-B); dominant negative
Citation Formats
Kim, Sun Kyung, Barron, Lindsey, Hinck, Cynthia S., Petrunak, Elyse M., Cano, Kristin E., Thangirala, Avinash, Iskra, Brian, Brothers, Molly, Vonberg, Machell, Leal, Belinda, Richter, Blair, Kodali, Ravindra, Taylor, Alexander B., Du, Shoucheng, Barnes, Christopher O., Sulea, Traian, Calero, Guillermo, Hart, P. John, Hart, Matthew J., Demeler, Borries, and Hinck, Andrew P. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling. United States: N. p., 2017.
Web. doi:10.1074/jbc.M116.768754.
Kim, Sun Kyung, Barron, Lindsey, Hinck, Cynthia S., Petrunak, Elyse M., Cano, Kristin E., Thangirala, Avinash, Iskra, Brian, Brothers, Molly, Vonberg, Machell, Leal, Belinda, Richter, Blair, Kodali, Ravindra, Taylor, Alexander B., Du, Shoucheng, Barnes, Christopher O., Sulea, Traian, Calero, Guillermo, Hart, P. John, Hart, Matthew J., Demeler, Borries, & Hinck, Andrew P. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling. United States. https://doi.org/10.1074/jbc.M116.768754
Kim, Sun Kyung, Barron, Lindsey, Hinck, Cynthia S., Petrunak, Elyse M., Cano, Kristin E., Thangirala, Avinash, Iskra, Brian, Brothers, Molly, Vonberg, Machell, Leal, Belinda, Richter, Blair, Kodali, Ravindra, Taylor, Alexander B., Du, Shoucheng, Barnes, Christopher O., Sulea, Traian, Calero, Guillermo, Hart, P. John, Hart, Matthew J., Demeler, Borries, and Hinck, Andrew P. Wed .
"An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling". United States. https://doi.org/10.1074/jbc.M116.768754. https://www.osti.gov/servlets/purl/1355043.
@article{osti_1355043,
title = {An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling},
author = {Kim, Sun Kyung and Barron, Lindsey and Hinck, Cynthia S. and Petrunak, Elyse M. and Cano, Kristin E. and Thangirala, Avinash and Iskra, Brian and Brothers, Molly and Vonberg, Machell and Leal, Belinda and Richter, Blair and Kodali, Ravindra and Taylor, Alexander B. and Du, Shoucheng and Barnes, Christopher O. and Sulea, Traian and Calero, Guillermo and Hart, P. John and Hart, Matthew J. and Demeler, Borries and Hinck, Andrew P.},
abstractNote = {The transforming growth factor β isoforms, TGF-β1, -β2, and -β3, are small secreted homodimeric signaling proteins with essential roles in regulating the adaptive immune system and maintaining the extracellular matrix. However, dysregulation of the TGF-β pathway is responsible for promoting the progression of several human diseases, including cancer and fibrosis. Despite the known importance of TGF-βs in promoting disease progression, no inhibitors have been approved for use in humans. Herein, we describe an engineered TGF-β monomer, lacking the heel helix, a structural motif essential for binding the TGF-β type I receptor (TβRI) but dispensable for binding the other receptor required for TGF-β signaling, the TGF-β type II receptor (TβRII), as an alternative therapeutic modality for blocking TGF-β signaling in humans. As shown through binding studies and crystallography, the engineered monomer retained the same overall structure of native TGF-β monomers and bound TβRII in an identical manner. Cell-based luciferase assays showed that the engineered monomer functioned as a dominant negative to inhibit TGF-β signaling with a Ki of 20–70 nM. Investigation of the mechanism showed that the high affinity of the engineered monomer for TβRII, coupled with its reduced ability to non-covalently dimerize and its inability to bind and recruit TβRI, enabled it to bind endogenous TβRII but prevented it from binding and recruiting TβRI to form a signaling complex. In conclusion, such engineered monomers provide a new avenue to probe and manipulate TGF-β signaling and may inform similar modifications of other TGF-β family members.},
doi = {10.1074/jbc.M116.768754},
journal = {Journal of Biological Chemistry},
number = 17,
volume = 292,
place = {United States},
year = {Wed Feb 22 00:00:00 EST 2017},
month = {Wed Feb 22 00:00:00 EST 2017}
}
Web of Science
Works referenced in this record:
Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor
journal, August 2006
- Loeys, Bart L.; Schwarze, Ulrike; Holm, Tammy
- New England Journal of Medicine, Vol. 355, Issue 8
Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins
journal, March 1993
- Grzesiek, Stephan; Bax, Ad
- Journal of Biomolecular NMR, Vol. 3, Issue 2
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily
journal, July 1992
- Daopin, S.; Piez, K.; Ogawa, Y.
- Science, Vol. 257, Issue 5068
Overview of the CCP 4 suite and current developments
journal, March 2011
- Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
- Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
Correlation of Backbone Amide and Aliphatic Side-Chain Resonances in 13C/15N-Enriched Proteins by Isotropic Mixing of 13C Magnetization
journal, February 1993
- Grzesiek, S.; Anglister, J.; Bax, A.
- Journal of Magnetic Resonance, Series B, Vol. 101, Issue 1
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs: TGF-β signals through autonomous TβRI:TβRII pairs
journal, March 2011
- Huang, Tao; David, Laurent; Mendoza, Valentín
- The EMBO Journal, Vol. 30, Issue 7
Biophysical and Biochemical Analysis of Recombinant Proteins
book, January 2008
- Arakawa, Tsutomu; Philo, John S.
- Pharmaceutical Biotechnology
Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily
journal, March 2010
- Radaev, Sergei; Zou, Zhongcheng; Huang, Tao
- Journal of Biological Chemistry, Vol. 285, Issue 19
Gdf-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding
journal, January 2001
- Tries, R. Scott; Chen, Tom; Da Vies, Monique V.
- Growth Factors, Vol. 18, Issue 4
Conformation and Self-association of Human Recombinant Transforming Growth Factor-β3 in Aqueous Solutions
journal, March 1999
- Pellaud, Jérôme; Schote, Uwe; Arvinte, Tudor
- Journal of Biological Chemistry, Vol. 274, Issue 12
Assembly of TβRI:TβRII:TGFβ Ternary Complex in vitro with Receptor Extracellular Domains is Cooperative and Isoform-dependent
journal, December 2005
- Zúñiga, Jorge E.; Groppe, Jay C.; Cui, Yumin
- Journal of Molecular Biology, Vol. 354, Issue 5
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
journal, June 2002
- Muraoka, Rebecca S.; Dumont, Nancy; Ritter, Christoph A.
- Journal of Clinical Investigation, Vol. 109, Issue 12
Pharmacokinetics and Half-Life of Protein Therapeutics
book, January 2012
- Meibohm, Bernd
- Therapeutic Proteins: Strategies to Modulate Their Plasma Half‐Lives
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling
journal, July 2004
- Ge, Rongrong; Rajeev, Vaishali; Subramanian, Gayathri
- Biochemical Pharmacology, Vol. 68, Issue 1
Backbone dynamics of proteins as studied by nitrogen-15 inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease
journal, November 1989
- Kay, Lewis E.; Torchia, Dennis A.; Bax, Ad
- Biochemistry, Vol. 28, Issue 23
TGF-β signaling in fibrosis
journal, July 2011
- Biernacka, Anna; Dobaczewski, Marcin; Frangogiannis, Nikolaos G.
- Growth Factors, Vol. 29, Issue 5
Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo
journal, December 2013
- Miao, Zhi-Feng; Zhao, Ting-Ting; Wang, Zhen-Ning
- Tumor Biology, Vol. 35, Issue 4
XDS
journal, January 2010
- Kabsch, Wolfgang
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
Three-dimensional triple-resonance NMR Spectroscopy of isotopically enriched proteins
journal, December 2011
- Kay, Lewis E.; Ikura, Mitsuhiko; Tschudin, Rolf
- Journal of Magnetic Resonance, Vol. 213, Issue 2
Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase Inhibitor
journal, July 2006
- Bandyopadhyay, Abhik; Agyin, Joseph K.; Wang, Long
- Cancer Research, Vol. 66, Issue 13
An Anti-Transforming Growth Factor Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
journal, May 2008
- Nam, J. -S.; Terabe, M.; Mamura, M.
- Cancer Research, Vol. 68, Issue 10
Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II Receptor
journal, January 2006
- De Crescenzo, Gregory; Hinck, Cynthia S.; Shu, Zhanyong
- Journal of Molecular Biology, Vol. 355, Issue 1
The crystal structure of TGF-β3 and comparison to TGF-β2: Implications for receptor binding
journal, July 1996
- Mittl, Peer R. E.; Priestle, John P.; Cox, David A.
- Protein Science, Vol. 5, Issue 7
Mechanism of activation of the TGF-β receptor
journal, August 1994
- Wrana, Jeffrey L.; Attisano, Liliana; Wieser, Rotraud
- Nature, Vol. 370, Issue 6488
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
journal, July 1991
- Dietz, Harry C.; Cutting, Carry R.; Pyeritz, Reed E.
- Nature, Vol. 352, Issue 6333
Tumor suppressor activity of the TGF-β pathway in human cancers
journal, June 1996
- Markowitz, S.
- Cytokine & Growth Factor Reviews, Vol. 7, Issue 1
Characterization of Reversible Associations by Sedimentation Velocity with UltraScan
journal, June 2010
- Demeler, Borries; Brookes, Emre; Wang, Renjing
- Macromolecular Bioscience, Vol. 10, Issue 7
Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation
journal, August 2013
- Robertson, Ian B.; Rifkin, Daniel B.
- Cytokine & Growth Factor Reviews, Vol. 24, Issue 4
Cooperative Assembly of TGF-β Superfamily Signaling Complexes Is Mediated by Two Disparate Mechanisms and Distinct Modes of Receptor Binding
journal, February 2008
- Groppe, Jay; Hinck, Cynthia S.; Samavarchi-Tehrani, Payman
- Molecular Cell, Vol. 29, Issue 2
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis
journal, October 2006
- Yamada, M.; Kuwano, K.; Maeyama, T.
- Journal of Clinical Pathology, Vol. 60, Issue 8
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
journal, March 2011
- Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen
- Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
journal, December 2014
- Lee, Woonghee; Tonelli, Marco; Markley, John L.
- Bioinformatics, Vol. 31, Issue 8
Modeling Analytical Ultracentrifugation Experiments with an Adaptive Space-Time Finite Element Solution for Multicomponent Reacting Systems
journal, July 2008
- Cao, Weiming; Demeler, Borries
- Biophysical Journal, Vol. 95, Issue 1
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
journal, June 2002
- Muraoka, Rebecca S.; Dumont, Nancy; Ritter, Christoph A.
- Journal of Clinical Investigation, Vol. 109, Issue 12
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
journal, January 2010
- Ganapathy, Vidya; Ge, Rongrong; Grazioli, Alison
- Molecular Cancer, Vol. 9, Issue 1
Features and development of Coot
journal, March 2010
- Emsley, P.; Lohkamp, B.; Scott, W. G.
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
Transforming growth factor signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures
journal, February 2009
- Di Sabatino, A.; Jackson, C. L.; Pickard, K. M.
- Gut, Vol. 58, Issue 6
The 1.1 Å Crystal Structure of Human TGF-β Type II Receptor Ligand Binding Domain
journal, July 2002
- Boesen, Christian C.; Radaev, Sergei; Motyka, Shawn A.
- Structure, Vol. 10, Issue 7
PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
journal, January 2011
- Connolly, E. C.; Saunier, E. F.; Quigley, D.
- Cancer Research, Vol. 71, Issue 6
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
journal, June 2002
- Yang, Yu-an; Dukhanina, Oksana; Tang, Binwu
- Journal of Clinical Investigation, Vol. 109, Issue 12
Monte Carlo analysis of sedimentation experiments
journal, June 2007
- Demeler, Borries; Brookes, Emre
- Colloid and Polymer Science, Vol. 286, Issue 2, p. 129-137
Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins
journal, October 1990
- Kay, Lewis E.; Ikura, Mitsuhiko; Tschudin, Rolf
- Journal of Magnetic Resonance (1969), Vol. 89, Issue 3
Tgf-β Signal Transduction
journal, June 1998
- Massagué, J.
- Annual Review of Biochemistry, Vol. 67, Issue 1
HNCACB, a High-Sensitivity 3D NMR Experiment to Correlate Amide-Proton and Nitrogen Resonances with the Alpha- and Beta-Carbon Resonances in Proteins
journal, April 1993
- Wittekind, M.; Mueller, L.
- Journal of Magnetic Resonance, Series B, Vol. 101, Issue 2
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
journal, November 1995
- Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW.
- Journal of Biomolecular NMR, Vol. 6, Issue 3
Development of TGF-β signalling inhibitors for cancer therapy
journal, December 2004
- Yingling, Jonathan M.; Blanchard, Kerry L.; Sawyer, J. Scott
- Nature Reviews Drug Discovery, Vol. 3, Issue 12
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and v 3 integrin
journal, August 2011
- Papo, N.; Silverman, A. P.; Lahti, J. L.
- Proceedings of the National Academy of Sciences, Vol. 108, Issue 34
TGFβ signals through a heteromeric protein kinase receptor complex
journal, December 1992
- Wrana, Jeffrey L.; Attisano, Liliana; Cárcamo, Juan
- Cell, Vol. 71, Issue 6
Transforming Growth Factor β1: Three-Dimensional Structure in Solution and Comparison with the X-ray Structure of Transforming Growth Factor β2 † , ‡
journal, January 1996
- Hinck, Andrew P.; Archer, Sharon J.; Qian, Su Wen
- Biochemistry, Vol. 35, Issue 26
Methods for the Design and Analysis of Sedimentation Velocity and Sedimentation Equilibrium Experiments with Proteins
journal, April 2010
- Demeler, Borries
- Current Protocols in Protein Science, Vol. 60, Issue 1
Antibody Targeting of TGF-β in Cancer Patients
journal, December 2011
- Lonning, Scott; Mannick, Joan; M. McPherson, John
- Current Pharmaceutical Biotechnology, Vol. 12, Issue 12
Structural Biology and Evolution of the TGF-β Family
journal, September 2016
- Hinck, Andrew P.; Mueller, Thomas D.; Springer, Timothy A.
- Cold Spring Harbor Perspectives in Biology, Vol. 8, Issue 12
Complexities of TGF-β Targeted Cancer Therapy
journal, January 2012
- Connolly, Erin C.; Freimuth, Julia; Akhurst, Rosemary J.
- International Journal of Biological Sciences, Vol. 8, Issue 7
Exploring anti-TGF-β therapies in cancer and fibrosis
journal, June 2011
- Hawinkels, Lukas J. A. C.; ten Dijke, Peter
- Growth Factors, Vol. 29, Issue 4
Activin signaling through activin receptor type II causes the cachexia- like symptoms in inhibin-deficient mice
journal, May 1996
- Coerver, K. A.
- Molecular Endocrinology, Vol. 10, Issue 5
Overexpression of human transforming growth factor-β1 using a recombinant CHO cell expression system
journal, October 2004
- Zou, Zhongcheng; Sun, Peter D.
- Protein Expression and Purification, Vol. 37, Issue 2
Phaser crystallographic software
journal, July 2007
- McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
- Journal of Applied Crystallography, Vol. 40, Issue 4
Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
journal, May 2012
- Hinck, Andrew P.
- FEBS Letters, Vol. 586, Issue 14
TβR-II Discriminates the High- and Low-Affinity TGF-β Isoforms via Two Hydrogen-Bonded Ion Pairs †
journal, March 2009
- Baardsnes, Jason; Hinck, Cynthia S.; Hinck, Andrew P.
- Biochemistry, Vol. 48, Issue 10
Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II
journal, May 1991
- Laiho, M.; Weis, F. M.; Boyd, F. T.
- Journal of Biological Chemistry, Vol. 266, Issue 14
[Ser77]transforming growth factor-beta 1. Selective biological activity and receptor binding in mink lung epithelial cells.
journal, November 1994
- Amatayakul-Chantler, S.; Qian, S. W.; Gakenheimer, K.
- Journal of Biological Chemistry, Vol. 269, Issue 44
[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997
- Otwinowski, Zbyszek; Minor, Wladek
- Macromolecular Crystallography Part A, 307-326
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
journal, March 2021
- Jalalirad, Mohammad; Haddad, Tufia C.; Salisbury, Jeffrey L.
- Oncogene, Vol. 40, Issue 14
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
journal, December 2019
- Sharma, Deepti; De Falco, Louis; Padavattan, Sivaraman
- Nature Communications, Vol. 10, Issue 1
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
journal, February 2021
- Tillu, Vikas A.; Rae, James; Gao, Ya
- Nature Communications, Vol. 12, Issue 1
Multi-functionality of a tryptophan residue conserved in substrate-binding groove of GH19 chitinases
journal, January 2021
- Nagata, Takuya; Shinya, Shoko; Ohnuma, Takayuki
- Scientific Reports, Vol. 11, Issue 1
Overview of the CCP4 suite and current developments.
text, January 2011
- Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
- Apollo - University of Cambridge Repository
Biophysical and Biochemical Analysis of Recombinant Proteins
book, October 2007
- Arakawa, Tsutomu; Philo, John
- Pharmaceutical Biotechnology
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
text, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Apollo - University of Cambridge Repository
Works referencing / citing this record:
Effects of Microcystin-LR on the Microstructure and Inflammation-Related Factors of Jejunum in Mice
journal, August 2019
- Cao, Linghui; Huang, Feiyu; Massey, Isaac Yaw
- Toxins, Vol. 11, Issue 9
TGF-β2 uses the concave surface of its extended finger region to bind betaglycan's ZP domain via three residues specific to TGF-β and inhibin-α
journal, December 2018
- Henen, Morkos A.; Mahlawat, Pardeep; Zwieb, Christian
- Journal of Biological Chemistry, Vol. 294, Issue 9
Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation
journal, June 2019
- del Amo-Maestro, Laura; Marino-Puertas, Laura; Goulas, Theodoros
- Scientific Reports, Vol. 9, Issue 1
Solving a new R2lox protein structure by microcrystal electron diffraction
journal, August 2019
- Xu, Hongyi; Lebrette, Hugo; Clabbers, Max T. B.
- Science Advances, Vol. 5, Issue 8